FASEB JOURNAL-期刊论坛，投稿经验-MedSci.cn

[GetPortalCommentsPageByObjectIdResponse(id=586690, encodeId=8fb65866902f, content=投稿一周多一直未收到投稿成功的邮件，也没有收到让提交copyright form的邮件，状态一直显示under consideration，请问正常吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=132, replyNumber=26, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=48f72026937, createdName=轩儿_8286, createdTime=Sun Mar 15 23:17:00 CST 2020, time=2020-03-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=858595, encodeId=f66585859599, content=1.15投稿，1.17送审，2.13返回，2.17告知我考虑接收，回答问题，3.3再提交，3.6接收，3.19 online。 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=178, replyNumber=20, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0a435414069, createdName=ms9690745155970328, createdTime=Fri Mar 20 13:04:00 CST 2020, time=2020-03-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1225915, encodeId=0d6812259156f, content=投稿后一直未收到投稿成功的邮件，状态一直为under consideration这正常吗 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=54, replyNumber=20, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/DYAIOgq83eoKCng4uCdGZjFNF1IthNcmvLiakicE0nk1nGRicymwCUNf8EegvLJ0mKnBXAribLln3Nmkqo2tTjwQaw/132, createdBy=d6d35154124, createdName=长春西汀, createdTime=Sun Jun 12 07:15:13 CST 2022, time=2022-06-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2144084, encodeId=918b214408459, content=审稿速度:2.0 偏重的研究方向：生物分子学 经验分享：第一次外审回来了14天了，编辑部都没给我返回评审意见。一直卡在编辑部。 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=43, replyNumber=17, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ff685697071, createdName=ms5000001632088774, createdTime=Wed Jun 21 12:25:44 CST 2023, time=2023-06-21, status=1, ipAttribution=湖南省), GetPortalCommentsPageByObjectIdResponse(id=806593, encodeId=cb008065931d, content=投了一个月还在Under consideration，请问一下各位，这个杂志的状态有哪些哦, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=191, replyNumber=16, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/vp81ML0pFfyNwFwGEx9Pw33qtqCn5M04bic15eUEPrwph5jOCicrTRKvKUX6JT7fiawspFQ85y9bCFrahoBiagwsSw/132, createdBy=faf35236748, createdName=治愈., createdTime=Thu Aug 06 18:10:30 CST 2020, time=2020-08-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1068771, encodeId=7c051068e71eb, content=审稿速度:1.0 | 审稿费用:50.0 经验分享：这是啥意思啊？是为什么一个out for review后，接着一个under consideration？是审稿专家看了一眼就要拒了吗？还是接受审稿要求呢 Out for review 2021-11-08 21:08 Under consideration 2021-11-08 21:08 Out for review 2021-11-08 19:00 Under consideration 2021-11-08 19:00 Out for review 2021-11-08 17:42 Under consideration 2021-11-01 21:56 Preliminary Submission Data Submitted 2021-11-01 11:18, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=72, replyNumber=15, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=9b882996665, createdName=916603706, createdTime=Tue Nov 09 22:15:53 CST 2021, time=2021-11-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2103249, encodeId=63e72103249b3, content=审稿速度:2.0 | 投稿命中率:25.0 偏重的研究方向：细胞生物学;表观遗传 经验分享：历时5个月，两次大修，今天终于接收了！编辑很严谨、认真！审稿人很专业，提的问题很尖锐，逐条据理力争。终于看到曙光了。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=55, replyNumber=13, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2018/06/01/fbe3b528d5156068cb776435797b7740.jpg, createdBy=d1f22181383, createdName=YBY0804, createdTime=Tue Nov 29 10:12:29 CST 2022, time=2022-11-29, status=1, ipAttribution=河南省), GetPortalCommentsPageByObjectIdResponse(id=2143105, encodeId=202a2143105af, content=审稿速度:6.0 | 投稿命中率:50.0 经验分享：这个杂志即便选择订阅模式，不OA，也要交2800美金版面费？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=41, replyNumber=9, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=f27764445, createdName=tjutiger, createdTime=Fri Jun 16 11:06:34 CST 2023, time=2023-06-16, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2121367, encodeId=1be6212136ea6, content=偏重的研究方向：生物学 经验分享：二审过了7天了，还是没有消息，害, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=50, replyNumber=9, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ac658288936, createdName=ms8000000700114189, createdTime=Thu Mar 23 16:30:08 CST 2023, time=2023-03-23, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2091430, encodeId=6f3f209143089, content=请问大家二审大概要多久啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=40, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=07598350548, createdName=ms6000002054557408, createdTime=Sun Oct 02 07:56:34 CST 2022, time=2022-10-02, status=1, ipAttribution=)]

2020-03-15 轩儿_8286

投稿一周多一直未收到投稿成功的邮件，也没有收到让提交copyright form的邮件，状态一直显示under consideration，请问正常吗？

132 26

展开26条回复

[GetPortalCommentsPageByObjectIdResponse(id=586690, encodeId=8fb65866902f, content=投稿一周多一直未收到投稿成功的邮件，也没有收到让提交copyright form的邮件，状态一直显示under consideration，请问正常吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=132, replyNumber=26, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=48f72026937, createdName=轩儿_8286, createdTime=Sun Mar 15 23:17:00 CST 2020, time=2020-03-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=858595, encodeId=f66585859599, content=1.15投稿，1.17送审，2.13返回，2.17告知我考虑接收，回答问题，3.3再提交，3.6接收，3.19 online。 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=178, replyNumber=20, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0a435414069, createdName=ms9690745155970328, createdTime=Fri Mar 20 13:04:00 CST 2020, time=2020-03-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1225915, encodeId=0d6812259156f, content=投稿后一直未收到投稿成功的邮件，状态一直为under consideration这正常吗 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=54, replyNumber=20, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/DYAIOgq83eoKCng4uCdGZjFNF1IthNcmvLiakicE0nk1nGRicymwCUNf8EegvLJ0mKnBXAribLln3Nmkqo2tTjwQaw/132, createdBy=d6d35154124, createdName=长春西汀, createdTime=Sun Jun 12 07:15:13 CST 2022, time=2022-06-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2144084, encodeId=918b214408459, content=审稿速度:2.0 偏重的研究方向：生物分子学 经验分享：第一次外审回来了14天了，编辑部都没给我返回评审意见。一直卡在编辑部。 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=43, replyNumber=17, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ff685697071, createdName=ms5000001632088774, createdTime=Wed Jun 21 12:25:44 CST 2023, time=2023-06-21, status=1, ipAttribution=湖南省), GetPortalCommentsPageByObjectIdResponse(id=806593, encodeId=cb008065931d, content=投了一个月还在Under consideration，请问一下各位，这个杂志的状态有哪些哦, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=191, replyNumber=16, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/vp81ML0pFfyNwFwGEx9Pw33qtqCn5M04bic15eUEPrwph5jOCicrTRKvKUX6JT7fiawspFQ85y9bCFrahoBiagwsSw/132, createdBy=faf35236748, createdName=治愈., createdTime=Thu Aug 06 18:10:30 CST 2020, time=2020-08-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1068771, encodeId=7c051068e71eb, content=审稿速度:1.0 | 审稿费用:50.0 经验分享：这是啥意思啊？是为什么一个out for review后，接着一个under consideration？是审稿专家看了一眼就要拒了吗？还是接受审稿要求呢 Out for review 2021-11-08 21:08 Under consideration 2021-11-08 21:08 Out for review 2021-11-08 19:00 Under consideration 2021-11-08 19:00 Out for review 2021-11-08 17:42 Under consideration 2021-11-01 21:56 Preliminary Submission Data Submitted 2021-11-01 11:18, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=72, replyNumber=15, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=9b882996665, createdName=916603706, createdTime=Tue Nov 09 22:15:53 CST 2021, time=2021-11-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2103249, encodeId=63e72103249b3, content=审稿速度:2.0 | 投稿命中率:25.0 偏重的研究方向：细胞生物学;表观遗传 经验分享：历时5个月，两次大修，今天终于接收了！编辑很严谨、认真！审稿人很专业，提的问题很尖锐，逐条据理力争。终于看到曙光了。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=55, replyNumber=13, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2018/06/01/fbe3b528d5156068cb776435797b7740.jpg, createdBy=d1f22181383, createdName=YBY0804, createdTime=Tue Nov 29 10:12:29 CST 2022, time=2022-11-29, status=1, ipAttribution=河南省), GetPortalCommentsPageByObjectIdResponse(id=2143105, encodeId=202a2143105af, content=审稿速度:6.0 | 投稿命中率:50.0 经验分享：这个杂志即便选择订阅模式，不OA，也要交2800美金版面费？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=41, replyNumber=9, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=f27764445, createdName=tjutiger, createdTime=Fri Jun 16 11:06:34 CST 2023, time=2023-06-16, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2121367, encodeId=1be6212136ea6, content=偏重的研究方向：生物学 经验分享：二审过了7天了，还是没有消息，害, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=50, replyNumber=9, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ac658288936, createdName=ms8000000700114189, createdTime=Thu Mar 23 16:30:08 CST 2023, time=2023-03-23, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2091430, encodeId=6f3f209143089, content=请问大家二审大概要多久啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=40, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=07598350548, createdName=ms6000002054557408, createdTime=Sun Oct 02 07:56:34 CST 2022, time=2022-10-02, status=1, ipAttribution=)]

2020-03-20 ms9690745155970328

1.15投稿，1.17送审，2.13返回，2.17告知我考虑接收，回答问题，3.3再提交，3.6接收，3.19 online。

178 20

展开20条回复

[GetPortalCommentsPageByObjectIdResponse(id=586690, encodeId=8fb65866902f, content=投稿一周多一直未收到投稿成功的邮件，也没有收到让提交copyright form的邮件，状态一直显示under consideration，请问正常吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=132, replyNumber=26, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=48f72026937, createdName=轩儿_8286, createdTime=Sun Mar 15 23:17:00 CST 2020, time=2020-03-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=858595, encodeId=f66585859599, content=1.15投稿，1.17送审，2.13返回，2.17告知我考虑接收，回答问题，3.3再提交，3.6接收，3.19 online。 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=178, replyNumber=20, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0a435414069, createdName=ms9690745155970328, createdTime=Fri Mar 20 13:04:00 CST 2020, time=2020-03-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1225915, encodeId=0d6812259156f, content=投稿后一直未收到投稿成功的邮件，状态一直为under consideration这正常吗 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=54, replyNumber=20, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/DYAIOgq83eoKCng4uCdGZjFNF1IthNcmvLiakicE0nk1nGRicymwCUNf8EegvLJ0mKnBXAribLln3Nmkqo2tTjwQaw/132, createdBy=d6d35154124, createdName=长春西汀, createdTime=Sun Jun 12 07:15:13 CST 2022, time=2022-06-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2144084, encodeId=918b214408459, content=审稿速度:2.0 偏重的研究方向：生物分子学 经验分享：第一次外审回来了14天了，编辑部都没给我返回评审意见。一直卡在编辑部。 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=43, replyNumber=17, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ff685697071, createdName=ms5000001632088774, createdTime=Wed Jun 21 12:25:44 CST 2023, time=2023-06-21, status=1, ipAttribution=湖南省), GetPortalCommentsPageByObjectIdResponse(id=806593, encodeId=cb008065931d, content=投了一个月还在Under consideration，请问一下各位，这个杂志的状态有哪些哦, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=191, replyNumber=16, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/vp81ML0pFfyNwFwGEx9Pw33qtqCn5M04bic15eUEPrwph5jOCicrTRKvKUX6JT7fiawspFQ85y9bCFrahoBiagwsSw/132, createdBy=faf35236748, createdName=治愈., createdTime=Thu Aug 06 18:10:30 CST 2020, time=2020-08-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1068771, encodeId=7c051068e71eb, content=审稿速度:1.0 | 审稿费用:50.0 经验分享：这是啥意思啊？是为什么一个out for review后，接着一个under consideration？是审稿专家看了一眼就要拒了吗？还是接受审稿要求呢 Out for review 2021-11-08 21:08 Under consideration 2021-11-08 21:08 Out for review 2021-11-08 19:00 Under consideration 2021-11-08 19:00 Out for review 2021-11-08 17:42 Under consideration 2021-11-01 21:56 Preliminary Submission Data Submitted 2021-11-01 11:18, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=72, replyNumber=15, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=9b882996665, createdName=916603706, createdTime=Tue Nov 09 22:15:53 CST 2021, time=2021-11-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2103249, encodeId=63e72103249b3, content=审稿速度:2.0 | 投稿命中率:25.0 偏重的研究方向：细胞生物学;表观遗传 经验分享：历时5个月，两次大修，今天终于接收了！编辑很严谨、认真！审稿人很专业，提的问题很尖锐，逐条据理力争。终于看到曙光了。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=55, replyNumber=13, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2018/06/01/fbe3b528d5156068cb776435797b7740.jpg, createdBy=d1f22181383, createdName=YBY0804, createdTime=Tue Nov 29 10:12:29 CST 2022, time=2022-11-29, status=1, ipAttribution=河南省), GetPortalCommentsPageByObjectIdResponse(id=2143105, encodeId=202a2143105af, content=审稿速度:6.0 | 投稿命中率:50.0 经验分享：这个杂志即便选择订阅模式，不OA，也要交2800美金版面费？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=41, replyNumber=9, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=f27764445, createdName=tjutiger, createdTime=Fri Jun 16 11:06:34 CST 2023, time=2023-06-16, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2121367, encodeId=1be6212136ea6, content=偏重的研究方向：生物学 经验分享：二审过了7天了，还是没有消息，害, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=50, replyNumber=9, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ac658288936, createdName=ms8000000700114189, createdTime=Thu Mar 23 16:30:08 CST 2023, time=2023-03-23, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2091430, encodeId=6f3f209143089, content=请问大家二审大概要多久啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=40, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=07598350548, createdName=ms6000002054557408, createdTime=Sun Oct 02 07:56:34 CST 2022, time=2022-10-02, status=1, ipAttribution=)]

2022-06-12 长春西汀

投稿后一直未收到投稿成功的邮件，状态一直为under consideration这正常吗

54 20

展开20条回复

[GetPortalCommentsPageByObjectIdResponse(id=586690, encodeId=8fb65866902f, content=投稿一周多一直未收到投稿成功的邮件，也没有收到让提交copyright form的邮件，状态一直显示under consideration，请问正常吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=132, replyNumber=26, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=48f72026937, createdName=轩儿_8286, createdTime=Sun Mar 15 23:17:00 CST 2020, time=2020-03-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=858595, encodeId=f66585859599, content=1.15投稿，1.17送审，2.13返回，2.17告知我考虑接收，回答问题，3.3再提交，3.6接收，3.19 online。 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=178, replyNumber=20, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0a435414069, createdName=ms9690745155970328, createdTime=Fri Mar 20 13:04:00 CST 2020, time=2020-03-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1225915, encodeId=0d6812259156f, content=投稿后一直未收到投稿成功的邮件，状态一直为under consideration这正常吗 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=54, replyNumber=20, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/DYAIOgq83eoKCng4uCdGZjFNF1IthNcmvLiakicE0nk1nGRicymwCUNf8EegvLJ0mKnBXAribLln3Nmkqo2tTjwQaw/132, createdBy=d6d35154124, createdName=长春西汀, createdTime=Sun Jun 12 07:15:13 CST 2022, time=2022-06-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2144084, encodeId=918b214408459, content=审稿速度:2.0 偏重的研究方向：生物分子学 经验分享：第一次外审回来了14天了，编辑部都没给我返回评审意见。一直卡在编辑部。 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=43, replyNumber=17, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ff685697071, createdName=ms5000001632088774, createdTime=Wed Jun 21 12:25:44 CST 2023, time=2023-06-21, status=1, ipAttribution=湖南省), GetPortalCommentsPageByObjectIdResponse(id=806593, encodeId=cb008065931d, content=投了一个月还在Under consideration，请问一下各位，这个杂志的状态有哪些哦, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=191, replyNumber=16, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/vp81ML0pFfyNwFwGEx9Pw33qtqCn5M04bic15eUEPrwph5jOCicrTRKvKUX6JT7fiawspFQ85y9bCFrahoBiagwsSw/132, createdBy=faf35236748, createdName=治愈., createdTime=Thu Aug 06 18:10:30 CST 2020, time=2020-08-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1068771, encodeId=7c051068e71eb, content=审稿速度:1.0 | 审稿费用:50.0 经验分享：这是啥意思啊？是为什么一个out for review后，接着一个under consideration？是审稿专家看了一眼就要拒了吗？还是接受审稿要求呢 Out for review 2021-11-08 21:08 Under consideration 2021-11-08 21:08 Out for review 2021-11-08 19:00 Under consideration 2021-11-08 19:00 Out for review 2021-11-08 17:42 Under consideration 2021-11-01 21:56 Preliminary Submission Data Submitted 2021-11-01 11:18, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=72, replyNumber=15, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=9b882996665, createdName=916603706, createdTime=Tue Nov 09 22:15:53 CST 2021, time=2021-11-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2103249, encodeId=63e72103249b3, content=审稿速度:2.0 | 投稿命中率:25.0 偏重的研究方向：细胞生物学;表观遗传 经验分享：历时5个月，两次大修，今天终于接收了！编辑很严谨、认真！审稿人很专业，提的问题很尖锐，逐条据理力争。终于看到曙光了。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=55, replyNumber=13, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2018/06/01/fbe3b528d5156068cb776435797b7740.jpg, createdBy=d1f22181383, createdName=YBY0804, createdTime=Tue Nov 29 10:12:29 CST 2022, time=2022-11-29, status=1, ipAttribution=河南省), GetPortalCommentsPageByObjectIdResponse(id=2143105, encodeId=202a2143105af, content=审稿速度:6.0 | 投稿命中率:50.0 经验分享：这个杂志即便选择订阅模式，不OA，也要交2800美金版面费？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=41, replyNumber=9, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=f27764445, createdName=tjutiger, createdTime=Fri Jun 16 11:06:34 CST 2023, time=2023-06-16, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2121367, encodeId=1be6212136ea6, content=偏重的研究方向：生物学 经验分享：二审过了7天了，还是没有消息，害, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=50, replyNumber=9, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ac658288936, createdName=ms8000000700114189, createdTime=Thu Mar 23 16:30:08 CST 2023, time=2023-03-23, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2091430, encodeId=6f3f209143089, content=请问大家二审大概要多久啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=40, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=07598350548, createdName=ms6000002054557408, createdTime=Sun Oct 02 07:56:34 CST 2022, time=2022-10-02, status=1, ipAttribution=)]

2023-06-21 ms5000001632088774 来自湖南省

审稿速度:2.0
偏重的研究方向：生物分子学
经验分享：第一次外审回来了14天了，编辑部都没给我返回评审意见。一直卡在编辑部。

43 17

展开17条回复

[GetPortalCommentsPageByObjectIdResponse(id=586690, encodeId=8fb65866902f, content=投稿一周多一直未收到投稿成功的邮件，也没有收到让提交copyright form的邮件，状态一直显示under consideration，请问正常吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=132, replyNumber=26, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=48f72026937, createdName=轩儿_8286, createdTime=Sun Mar 15 23:17:00 CST 2020, time=2020-03-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=858595, encodeId=f66585859599, content=1.15投稿，1.17送审，2.13返回，2.17告知我考虑接收，回答问题，3.3再提交，3.6接收，3.19 online。 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=178, replyNumber=20, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0a435414069, createdName=ms9690745155970328, createdTime=Fri Mar 20 13:04:00 CST 2020, time=2020-03-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1225915, encodeId=0d6812259156f, content=投稿后一直未收到投稿成功的邮件，状态一直为under consideration这正常吗 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=54, replyNumber=20, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/DYAIOgq83eoKCng4uCdGZjFNF1IthNcmvLiakicE0nk1nGRicymwCUNf8EegvLJ0mKnBXAribLln3Nmkqo2tTjwQaw/132, createdBy=d6d35154124, createdName=长春西汀, createdTime=Sun Jun 12 07:15:13 CST 2022, time=2022-06-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2144084, encodeId=918b214408459, content=审稿速度:2.0 偏重的研究方向：生物分子学 经验分享：第一次外审回来了14天了，编辑部都没给我返回评审意见。一直卡在编辑部。 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=43, replyNumber=17, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ff685697071, createdName=ms5000001632088774, createdTime=Wed Jun 21 12:25:44 CST 2023, time=2023-06-21, status=1, ipAttribution=湖南省), GetPortalCommentsPageByObjectIdResponse(id=806593, encodeId=cb008065931d, content=投了一个月还在Under consideration，请问一下各位，这个杂志的状态有哪些哦, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=191, replyNumber=16, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/vp81ML0pFfyNwFwGEx9Pw33qtqCn5M04bic15eUEPrwph5jOCicrTRKvKUX6JT7fiawspFQ85y9bCFrahoBiagwsSw/132, createdBy=faf35236748, createdName=治愈., createdTime=Thu Aug 06 18:10:30 CST 2020, time=2020-08-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1068771, encodeId=7c051068e71eb, content=审稿速度:1.0 | 审稿费用:50.0 经验分享：这是啥意思啊？是为什么一个out for review后，接着一个under consideration？是审稿专家看了一眼就要拒了吗？还是接受审稿要求呢 Out for review 2021-11-08 21:08 Under consideration 2021-11-08 21:08 Out for review 2021-11-08 19:00 Under consideration 2021-11-08 19:00 Out for review 2021-11-08 17:42 Under consideration 2021-11-01 21:56 Preliminary Submission Data Submitted 2021-11-01 11:18, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=72, replyNumber=15, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=9b882996665, createdName=916603706, createdTime=Tue Nov 09 22:15:53 CST 2021, time=2021-11-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2103249, encodeId=63e72103249b3, content=审稿速度:2.0 | 投稿命中率:25.0 偏重的研究方向：细胞生物学;表观遗传 经验分享：历时5个月，两次大修，今天终于接收了！编辑很严谨、认真！审稿人很专业，提的问题很尖锐，逐条据理力争。终于看到曙光了。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=55, replyNumber=13, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2018/06/01/fbe3b528d5156068cb776435797b7740.jpg, createdBy=d1f22181383, createdName=YBY0804, createdTime=Tue Nov 29 10:12:29 CST 2022, time=2022-11-29, status=1, ipAttribution=河南省), GetPortalCommentsPageByObjectIdResponse(id=2143105, encodeId=202a2143105af, content=审稿速度:6.0 | 投稿命中率:50.0 经验分享：这个杂志即便选择订阅模式，不OA，也要交2800美金版面费？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=41, replyNumber=9, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=f27764445, createdName=tjutiger, createdTime=Fri Jun 16 11:06:34 CST 2023, time=2023-06-16, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2121367, encodeId=1be6212136ea6, content=偏重的研究方向：生物学 经验分享：二审过了7天了，还是没有消息，害, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=50, replyNumber=9, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ac658288936, createdName=ms8000000700114189, createdTime=Thu Mar 23 16:30:08 CST 2023, time=2023-03-23, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2091430, encodeId=6f3f209143089, content=请问大家二审大概要多久啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=40, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=07598350548, createdName=ms6000002054557408, createdTime=Sun Oct 02 07:56:34 CST 2022, time=2022-10-02, status=1, ipAttribution=)]

2020-08-06 治愈.

投了一个月还在Under consideration，请问一下各位，这个杂志的状态有哪些哦

191 16

展开16条回复

[GetPortalCommentsPageByObjectIdResponse(id=586690, encodeId=8fb65866902f, content=投稿一周多一直未收到投稿成功的邮件，也没有收到让提交copyright form的邮件，状态一直显示under consideration，请问正常吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=132, replyNumber=26, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=48f72026937, createdName=轩儿_8286, createdTime=Sun Mar 15 23:17:00 CST 2020, time=2020-03-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=858595, encodeId=f66585859599, content=1.15投稿，1.17送审，2.13返回，2.17告知我考虑接收，回答问题，3.3再提交，3.6接收，3.19 online。 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=178, replyNumber=20, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0a435414069, createdName=ms9690745155970328, createdTime=Fri Mar 20 13:04:00 CST 2020, time=2020-03-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1225915, encodeId=0d6812259156f, content=投稿后一直未收到投稿成功的邮件，状态一直为under consideration这正常吗 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=54, replyNumber=20, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/DYAIOgq83eoKCng4uCdGZjFNF1IthNcmvLiakicE0nk1nGRicymwCUNf8EegvLJ0mKnBXAribLln3Nmkqo2tTjwQaw/132, createdBy=d6d35154124, createdName=长春西汀, createdTime=Sun Jun 12 07:15:13 CST 2022, time=2022-06-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2144084, encodeId=918b214408459, content=审稿速度:2.0 偏重的研究方向：生物分子学 经验分享：第一次外审回来了14天了，编辑部都没给我返回评审意见。一直卡在编辑部。 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=43, replyNumber=17, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ff685697071, createdName=ms5000001632088774, createdTime=Wed Jun 21 12:25:44 CST 2023, time=2023-06-21, status=1, ipAttribution=湖南省), GetPortalCommentsPageByObjectIdResponse(id=806593, encodeId=cb008065931d, content=投了一个月还在Under consideration，请问一下各位，这个杂志的状态有哪些哦, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=191, replyNumber=16, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/vp81ML0pFfyNwFwGEx9Pw33qtqCn5M04bic15eUEPrwph5jOCicrTRKvKUX6JT7fiawspFQ85y9bCFrahoBiagwsSw/132, createdBy=faf35236748, createdName=治愈., createdTime=Thu Aug 06 18:10:30 CST 2020, time=2020-08-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1068771, encodeId=7c051068e71eb, content=审稿速度:1.0 | 审稿费用:50.0 经验分享：这是啥意思啊？是为什么一个out for review后，接着一个under consideration？是审稿专家看了一眼就要拒了吗？还是接受审稿要求呢 Out for review 2021-11-08 21:08 Under consideration 2021-11-08 21:08 Out for review 2021-11-08 19:00 Under consideration 2021-11-08 19:00 Out for review 2021-11-08 17:42 Under consideration 2021-11-01 21:56 Preliminary Submission Data Submitted 2021-11-01 11:18, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=72, replyNumber=15, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=9b882996665, createdName=916603706, createdTime=Tue Nov 09 22:15:53 CST 2021, time=2021-11-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2103249, encodeId=63e72103249b3, content=审稿速度:2.0 | 投稿命中率:25.0 偏重的研究方向：细胞生物学;表观遗传 经验分享：历时5个月，两次大修，今天终于接收了！编辑很严谨、认真！审稿人很专业，提的问题很尖锐，逐条据理力争。终于看到曙光了。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=55, replyNumber=13, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2018/06/01/fbe3b528d5156068cb776435797b7740.jpg, createdBy=d1f22181383, createdName=YBY0804, createdTime=Tue Nov 29 10:12:29 CST 2022, time=2022-11-29, status=1, ipAttribution=河南省), GetPortalCommentsPageByObjectIdResponse(id=2143105, encodeId=202a2143105af, content=审稿速度:6.0 | 投稿命中率:50.0 经验分享：这个杂志即便选择订阅模式，不OA，也要交2800美金版面费？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=41, replyNumber=9, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=f27764445, createdName=tjutiger, createdTime=Fri Jun 16 11:06:34 CST 2023, time=2023-06-16, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2121367, encodeId=1be6212136ea6, content=偏重的研究方向：生物学 经验分享：二审过了7天了，还是没有消息，害, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=50, replyNumber=9, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ac658288936, createdName=ms8000000700114189, createdTime=Thu Mar 23 16:30:08 CST 2023, time=2023-03-23, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2091430, encodeId=6f3f209143089, content=请问大家二审大概要多久啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=40, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=07598350548, createdName=ms6000002054557408, createdTime=Sun Oct 02 07:56:34 CST 2022, time=2022-10-02, status=1, ipAttribution=)]

2021-11-09 916603706

审稿速度:1.0 | 审稿费用:50.0
经验分享：这是啥意思啊？是为什么一个out for review后，接着一个under consideration？是审稿专家看了一眼就要拒了吗？还是接受审稿要求呢
Out for review 2021-11-08 21:08
Under consideration 2021-11-08 21:08
Out for review 2021-11-08 19:00
Under consideration 2021-11-08 19:00
Out for review 2021-11-08 17:42
Under consideration 2021-11-01 21:56
Preliminary Submission Data Submitted 2021-11-01 11:18

72 15

展开15条回复

[GetPortalCommentsPageByObjectIdResponse(id=586690, encodeId=8fb65866902f, content=投稿一周多一直未收到投稿成功的邮件，也没有收到让提交copyright form的邮件，状态一直显示under consideration，请问正常吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=132, replyNumber=26, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=48f72026937, createdName=轩儿_8286, createdTime=Sun Mar 15 23:17:00 CST 2020, time=2020-03-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=858595, encodeId=f66585859599, content=1.15投稿，1.17送审，2.13返回，2.17告知我考虑接收，回答问题，3.3再提交，3.6接收，3.19 online。 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=178, replyNumber=20, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0a435414069, createdName=ms9690745155970328, createdTime=Fri Mar 20 13:04:00 CST 2020, time=2020-03-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1225915, encodeId=0d6812259156f, content=投稿后一直未收到投稿成功的邮件，状态一直为under consideration这正常吗 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=54, replyNumber=20, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/DYAIOgq83eoKCng4uCdGZjFNF1IthNcmvLiakicE0nk1nGRicymwCUNf8EegvLJ0mKnBXAribLln3Nmkqo2tTjwQaw/132, createdBy=d6d35154124, createdName=长春西汀, createdTime=Sun Jun 12 07:15:13 CST 2022, time=2022-06-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2144084, encodeId=918b214408459, content=审稿速度:2.0 偏重的研究方向：生物分子学 经验分享：第一次外审回来了14天了，编辑部都没给我返回评审意见。一直卡在编辑部。 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=43, replyNumber=17, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ff685697071, createdName=ms5000001632088774, createdTime=Wed Jun 21 12:25:44 CST 2023, time=2023-06-21, status=1, ipAttribution=湖南省), GetPortalCommentsPageByObjectIdResponse(id=806593, encodeId=cb008065931d, content=投了一个月还在Under consideration，请问一下各位，这个杂志的状态有哪些哦, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=191, replyNumber=16, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/vp81ML0pFfyNwFwGEx9Pw33qtqCn5M04bic15eUEPrwph5jOCicrTRKvKUX6JT7fiawspFQ85y9bCFrahoBiagwsSw/132, createdBy=faf35236748, createdName=治愈., createdTime=Thu Aug 06 18:10:30 CST 2020, time=2020-08-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1068771, encodeId=7c051068e71eb, content=审稿速度:1.0 | 审稿费用:50.0 经验分享：这是啥意思啊？是为什么一个out for review后，接着一个under consideration？是审稿专家看了一眼就要拒了吗？还是接受审稿要求呢 Out for review 2021-11-08 21:08 Under consideration 2021-11-08 21:08 Out for review 2021-11-08 19:00 Under consideration 2021-11-08 19:00 Out for review 2021-11-08 17:42 Under consideration 2021-11-01 21:56 Preliminary Submission Data Submitted 2021-11-01 11:18, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=72, replyNumber=15, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=9b882996665, createdName=916603706, createdTime=Tue Nov 09 22:15:53 CST 2021, time=2021-11-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2103249, encodeId=63e72103249b3, content=审稿速度:2.0 | 投稿命中率:25.0 偏重的研究方向：细胞生物学;表观遗传 经验分享：历时5个月，两次大修，今天终于接收了！编辑很严谨、认真！审稿人很专业，提的问题很尖锐，逐条据理力争。终于看到曙光了。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=55, replyNumber=13, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2018/06/01/fbe3b528d5156068cb776435797b7740.jpg, createdBy=d1f22181383, createdName=YBY0804, createdTime=Tue Nov 29 10:12:29 CST 2022, time=2022-11-29, status=1, ipAttribution=河南省), GetPortalCommentsPageByObjectIdResponse(id=2143105, encodeId=202a2143105af, content=审稿速度:6.0 | 投稿命中率:50.0 经验分享：这个杂志即便选择订阅模式，不OA，也要交2800美金版面费？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=41, replyNumber=9, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=f27764445, createdName=tjutiger, createdTime=Fri Jun 16 11:06:34 CST 2023, time=2023-06-16, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2121367, encodeId=1be6212136ea6, content=偏重的研究方向：生物学 经验分享：二审过了7天了，还是没有消息，害, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=50, replyNumber=9, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ac658288936, createdName=ms8000000700114189, createdTime=Thu Mar 23 16:30:08 CST 2023, time=2023-03-23, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2091430, encodeId=6f3f209143089, content=请问大家二审大概要多久啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=40, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=07598350548, createdName=ms6000002054557408, createdTime=Sun Oct 02 07:56:34 CST 2022, time=2022-10-02, status=1, ipAttribution=)]

2022-11-29 YBY0804 来自河南省

审稿速度:2.0 | 投稿命中率:25.0
偏重的研究方向：细胞生物学;表观遗传
经验分享：历时5个月，两次大修，今天终于接收了！编辑很严谨、认真！审稿人很专业，提的问题很尖锐，逐条据理力争。终于看到曙光了。

55 13

展开13条回复

[GetPortalCommentsPageByObjectIdResponse(id=586690, encodeId=8fb65866902f, content=投稿一周多一直未收到投稿成功的邮件，也没有收到让提交copyright form的邮件，状态一直显示under consideration，请问正常吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=132, replyNumber=26, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=48f72026937, createdName=轩儿_8286, createdTime=Sun Mar 15 23:17:00 CST 2020, time=2020-03-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=858595, encodeId=f66585859599, content=1.15投稿，1.17送审，2.13返回，2.17告知我考虑接收，回答问题，3.3再提交，3.6接收，3.19 online。 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=178, replyNumber=20, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0a435414069, createdName=ms9690745155970328, createdTime=Fri Mar 20 13:04:00 CST 2020, time=2020-03-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1225915, encodeId=0d6812259156f, content=投稿后一直未收到投稿成功的邮件，状态一直为under consideration这正常吗 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=54, replyNumber=20, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/DYAIOgq83eoKCng4uCdGZjFNF1IthNcmvLiakicE0nk1nGRicymwCUNf8EegvLJ0mKnBXAribLln3Nmkqo2tTjwQaw/132, createdBy=d6d35154124, createdName=长春西汀, createdTime=Sun Jun 12 07:15:13 CST 2022, time=2022-06-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2144084, encodeId=918b214408459, content=审稿速度:2.0 偏重的研究方向：生物分子学 经验分享：第一次外审回来了14天了，编辑部都没给我返回评审意见。一直卡在编辑部。 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=43, replyNumber=17, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ff685697071, createdName=ms5000001632088774, createdTime=Wed Jun 21 12:25:44 CST 2023, time=2023-06-21, status=1, ipAttribution=湖南省), GetPortalCommentsPageByObjectIdResponse(id=806593, encodeId=cb008065931d, content=投了一个月还在Under consideration，请问一下各位，这个杂志的状态有哪些哦, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=191, replyNumber=16, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/vp81ML0pFfyNwFwGEx9Pw33qtqCn5M04bic15eUEPrwph5jOCicrTRKvKUX6JT7fiawspFQ85y9bCFrahoBiagwsSw/132, createdBy=faf35236748, createdName=治愈., createdTime=Thu Aug 06 18:10:30 CST 2020, time=2020-08-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1068771, encodeId=7c051068e71eb, content=审稿速度:1.0 | 审稿费用:50.0 经验分享：这是啥意思啊？是为什么一个out for review后，接着一个under consideration？是审稿专家看了一眼就要拒了吗？还是接受审稿要求呢 Out for review 2021-11-08 21:08 Under consideration 2021-11-08 21:08 Out for review 2021-11-08 19:00 Under consideration 2021-11-08 19:00 Out for review 2021-11-08 17:42 Under consideration 2021-11-01 21:56 Preliminary Submission Data Submitted 2021-11-01 11:18, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=72, replyNumber=15, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=9b882996665, createdName=916603706, createdTime=Tue Nov 09 22:15:53 CST 2021, time=2021-11-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2103249, encodeId=63e72103249b3, content=审稿速度:2.0 | 投稿命中率:25.0 偏重的研究方向：细胞生物学;表观遗传 经验分享：历时5个月，两次大修，今天终于接收了！编辑很严谨、认真！审稿人很专业，提的问题很尖锐，逐条据理力争。终于看到曙光了。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=55, replyNumber=13, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2018/06/01/fbe3b528d5156068cb776435797b7740.jpg, createdBy=d1f22181383, createdName=YBY0804, createdTime=Tue Nov 29 10:12:29 CST 2022, time=2022-11-29, status=1, ipAttribution=河南省), GetPortalCommentsPageByObjectIdResponse(id=2143105, encodeId=202a2143105af, content=审稿速度:6.0 | 投稿命中率:50.0 经验分享：这个杂志即便选择订阅模式，不OA，也要交2800美金版面费？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=41, replyNumber=9, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=f27764445, createdName=tjutiger, createdTime=Fri Jun 16 11:06:34 CST 2023, time=2023-06-16, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2121367, encodeId=1be6212136ea6, content=偏重的研究方向：生物学 经验分享：二审过了7天了，还是没有消息，害, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=50, replyNumber=9, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ac658288936, createdName=ms8000000700114189, createdTime=Thu Mar 23 16:30:08 CST 2023, time=2023-03-23, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2091430, encodeId=6f3f209143089, content=请问大家二审大概要多久啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=40, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=07598350548, createdName=ms6000002054557408, createdTime=Sun Oct 02 07:56:34 CST 2022, time=2022-10-02, status=1, ipAttribution=)]

2023-06-16 tjutiger 来自山东省

审稿速度:6.0 | 投稿命中率:50.0
经验分享：这个杂志即便选择订阅模式，不OA，也要交2800美金版面费？

41 9

展开9条回复

[GetPortalCommentsPageByObjectIdResponse(id=586690, encodeId=8fb65866902f, content=投稿一周多一直未收到投稿成功的邮件，也没有收到让提交copyright form的邮件，状态一直显示under consideration，请问正常吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=132, replyNumber=26, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=48f72026937, createdName=轩儿_8286, createdTime=Sun Mar 15 23:17:00 CST 2020, time=2020-03-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=858595, encodeId=f66585859599, content=1.15投稿，1.17送审，2.13返回，2.17告知我考虑接收，回答问题，3.3再提交，3.6接收，3.19 online。 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=178, replyNumber=20, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0a435414069, createdName=ms9690745155970328, createdTime=Fri Mar 20 13:04:00 CST 2020, time=2020-03-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1225915, encodeId=0d6812259156f, content=投稿后一直未收到投稿成功的邮件，状态一直为under consideration这正常吗 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=54, replyNumber=20, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/DYAIOgq83eoKCng4uCdGZjFNF1IthNcmvLiakicE0nk1nGRicymwCUNf8EegvLJ0mKnBXAribLln3Nmkqo2tTjwQaw/132, createdBy=d6d35154124, createdName=长春西汀, createdTime=Sun Jun 12 07:15:13 CST 2022, time=2022-06-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2144084, encodeId=918b214408459, content=审稿速度:2.0 偏重的研究方向：生物分子学 经验分享：第一次外审回来了14天了，编辑部都没给我返回评审意见。一直卡在编辑部。 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=43, replyNumber=17, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ff685697071, createdName=ms5000001632088774, createdTime=Wed Jun 21 12:25:44 CST 2023, time=2023-06-21, status=1, ipAttribution=湖南省), GetPortalCommentsPageByObjectIdResponse(id=806593, encodeId=cb008065931d, content=投了一个月还在Under consideration，请问一下各位，这个杂志的状态有哪些哦, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=191, replyNumber=16, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/vp81ML0pFfyNwFwGEx9Pw33qtqCn5M04bic15eUEPrwph5jOCicrTRKvKUX6JT7fiawspFQ85y9bCFrahoBiagwsSw/132, createdBy=faf35236748, createdName=治愈., createdTime=Thu Aug 06 18:10:30 CST 2020, time=2020-08-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1068771, encodeId=7c051068e71eb, content=审稿速度:1.0 | 审稿费用:50.0 经验分享：这是啥意思啊？是为什么一个out for review后，接着一个under consideration？是审稿专家看了一眼就要拒了吗？还是接受审稿要求呢 Out for review 2021-11-08 21:08 Under consideration 2021-11-08 21:08 Out for review 2021-11-08 19:00 Under consideration 2021-11-08 19:00 Out for review 2021-11-08 17:42 Under consideration 2021-11-01 21:56 Preliminary Submission Data Submitted 2021-11-01 11:18, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=72, replyNumber=15, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=9b882996665, createdName=916603706, createdTime=Tue Nov 09 22:15:53 CST 2021, time=2021-11-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2103249, encodeId=63e72103249b3, content=审稿速度:2.0 | 投稿命中率:25.0 偏重的研究方向：细胞生物学;表观遗传 经验分享：历时5个月，两次大修，今天终于接收了！编辑很严谨、认真！审稿人很专业，提的问题很尖锐，逐条据理力争。终于看到曙光了。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=55, replyNumber=13, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2018/06/01/fbe3b528d5156068cb776435797b7740.jpg, createdBy=d1f22181383, createdName=YBY0804, createdTime=Tue Nov 29 10:12:29 CST 2022, time=2022-11-29, status=1, ipAttribution=河南省), GetPortalCommentsPageByObjectIdResponse(id=2143105, encodeId=202a2143105af, content=审稿速度:6.0 | 投稿命中率:50.0 经验分享：这个杂志即便选择订阅模式，不OA，也要交2800美金版面费？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=41, replyNumber=9, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=f27764445, createdName=tjutiger, createdTime=Fri Jun 16 11:06:34 CST 2023, time=2023-06-16, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2121367, encodeId=1be6212136ea6, content=偏重的研究方向：生物学 经验分享：二审过了7天了，还是没有消息，害, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=50, replyNumber=9, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ac658288936, createdName=ms8000000700114189, createdTime=Thu Mar 23 16:30:08 CST 2023, time=2023-03-23, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2091430, encodeId=6f3f209143089, content=请问大家二审大概要多久啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=40, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=07598350548, createdName=ms6000002054557408, createdTime=Sun Oct 02 07:56:34 CST 2022, time=2022-10-02, status=1, ipAttribution=)]

2023-03-23 ms8000000700114189 来自广东省

偏重的研究方向：生物学
经验分享：二审过了7天了，还是没有消息，害

50 9

展开9条回复

[GetPortalCommentsPageByObjectIdResponse(id=586690, encodeId=8fb65866902f, content=投稿一周多一直未收到投稿成功的邮件，也没有收到让提交copyright form的邮件，状态一直显示under consideration，请问正常吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=132, replyNumber=26, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=48f72026937, createdName=轩儿_8286, createdTime=Sun Mar 15 23:17:00 CST 2020, time=2020-03-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=858595, encodeId=f66585859599, content=1.15投稿，1.17送审，2.13返回，2.17告知我考虑接收，回答问题，3.3再提交，3.6接收，3.19 online。 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=178, replyNumber=20, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0a435414069, createdName=ms9690745155970328, createdTime=Fri Mar 20 13:04:00 CST 2020, time=2020-03-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1225915, encodeId=0d6812259156f, content=投稿后一直未收到投稿成功的邮件，状态一直为under consideration这正常吗 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=54, replyNumber=20, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/DYAIOgq83eoKCng4uCdGZjFNF1IthNcmvLiakicE0nk1nGRicymwCUNf8EegvLJ0mKnBXAribLln3Nmkqo2tTjwQaw/132, createdBy=d6d35154124, createdName=长春西汀, createdTime=Sun Jun 12 07:15:13 CST 2022, time=2022-06-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2144084, encodeId=918b214408459, content=审稿速度:2.0 偏重的研究方向：生物分子学 经验分享：第一次外审回来了14天了，编辑部都没给我返回评审意见。一直卡在编辑部。 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=43, replyNumber=17, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ff685697071, createdName=ms5000001632088774, createdTime=Wed Jun 21 12:25:44 CST 2023, time=2023-06-21, status=1, ipAttribution=湖南省), GetPortalCommentsPageByObjectIdResponse(id=806593, encodeId=cb008065931d, content=投了一个月还在Under consideration，请问一下各位，这个杂志的状态有哪些哦, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=191, replyNumber=16, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/vp81ML0pFfyNwFwGEx9Pw33qtqCn5M04bic15eUEPrwph5jOCicrTRKvKUX6JT7fiawspFQ85y9bCFrahoBiagwsSw/132, createdBy=faf35236748, createdName=治愈., createdTime=Thu Aug 06 18:10:30 CST 2020, time=2020-08-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1068771, encodeId=7c051068e71eb, content=审稿速度:1.0 | 审稿费用:50.0 经验分享：这是啥意思啊？是为什么一个out for review后，接着一个under consideration？是审稿专家看了一眼就要拒了吗？还是接受审稿要求呢 Out for review 2021-11-08 21:08 Under consideration 2021-11-08 21:08 Out for review 2021-11-08 19:00 Under consideration 2021-11-08 19:00 Out for review 2021-11-08 17:42 Under consideration 2021-11-01 21:56 Preliminary Submission Data Submitted 2021-11-01 11:18, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=72, replyNumber=15, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=9b882996665, createdName=916603706, createdTime=Tue Nov 09 22:15:53 CST 2021, time=2021-11-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2103249, encodeId=63e72103249b3, content=审稿速度:2.0 | 投稿命中率:25.0 偏重的研究方向：细胞生物学;表观遗传 经验分享：历时5个月，两次大修，今天终于接收了！编辑很严谨、认真！审稿人很专业，提的问题很尖锐，逐条据理力争。终于看到曙光了。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=55, replyNumber=13, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2018/06/01/fbe3b528d5156068cb776435797b7740.jpg, createdBy=d1f22181383, createdName=YBY0804, createdTime=Tue Nov 29 10:12:29 CST 2022, time=2022-11-29, status=1, ipAttribution=河南省), GetPortalCommentsPageByObjectIdResponse(id=2143105, encodeId=202a2143105af, content=审稿速度:6.0 | 投稿命中率:50.0 经验分享：这个杂志即便选择订阅模式，不OA，也要交2800美金版面费？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=41, replyNumber=9, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=f27764445, createdName=tjutiger, createdTime=Fri Jun 16 11:06:34 CST 2023, time=2023-06-16, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2121367, encodeId=1be6212136ea6, content=偏重的研究方向：生物学 经验分享：二审过了7天了，还是没有消息，害, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=50, replyNumber=9, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ac658288936, createdName=ms8000000700114189, createdTime=Thu Mar 23 16:30:08 CST 2023, time=2023-03-23, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2091430, encodeId=6f3f209143089, content=请问大家二审大概要多久啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=40, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=07598350548, createdName=ms6000002054557408, createdTime=Sun Oct 02 07:56:34 CST 2022, time=2022-10-02, status=1, ipAttribution=)]

2022-10-02 ms6000002054557408

请问大家二审大概要多久啊

40 8

展开8条回复

内科

外科

专科科室

热点

按科室浏览

临床工具

科研工具

其他工具

科研数智化

真实世界研究解决方案

数字化学术传播解决方案

其它

期刊讨论

科室

工具

服务